275 related articles for article (PubMed ID: 26349954)
1. Pattern of Duplicate Presentations at National Hematology-Oncology Meetings: Influence of the Pharmaceutical Industry.
Ramchandren R; Schiffer CA
J Oncol Pract; 2016 Mar; 12(3):254-9, 252-3. PubMed ID: 26349954
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical Industry Influence on Duplicate Abstracts at National Oncology and Hematology Meetings.
Silver SM
J Oncol Pract; 2016 Mar; 12(3):199-200. PubMed ID: 26733625
[No Abstract] [Full Text] [Related]
3. The contribution of limited-resource countries to the American Society of Clinical Oncology annual meetings.
Masmoudi A
Int J Clin Oncol; 2009 Oct; 14(5):442-6. PubMed ID: 19856054
[TBL] [Abstract][Full Text] [Related]
4. Publication bias in pediatric hematology and oncology: analysis of abstracts presented at the annual meeting of the American Society of Pediatric Hematology and Oncology.
Salami K; Alkayed K
Pediatr Hematol Oncol; 2013 Apr; 30(3):165-9. PubMed ID: 23461713
[TBL] [Abstract][Full Text] [Related]
5. The influence of industry sponsorship on the acceptance of abstracts and their publication.
McLennan M; Leong FC; Steele A; Harris J
Am J Obstet Gynecol; 2008 May; 198(5):579.e1-4. PubMed ID: 18455539
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the Use and Impact of Twitter During American Society of Clinical Oncology Annual Meetings From 2011 to 2016: Focus on Advanced Metrics and User Trends.
Pemmaraju N; Thompson MA; Mesa RA; Desai T
J Oncol Pract; 2017 Jul; 13(7):e623-e631. PubMed ID: 28514195
[TBL] [Abstract][Full Text] [Related]
7. Duplicate presentations on prostate cancer at American Urological Association and European Association of Urology annual meetings.
Pop GH; Fesperman SF; Ball DA; Yeung LL; Vieweg J; Dahm P
J Urol; 2009 Aug; 182(2):674-8; discussion 678-9. PubMed ID: 19535105
[TBL] [Abstract][Full Text] [Related]
8. Analysis of duplicate presentations accepted at two top international pediatric urology meetings.
Kim S; Braga LH; Pemberton J; Demaria J; Lorenzo AJ
J Pediatr Urol; 2012 Jun; 8(3):291-5. PubMed ID: 21439908
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with failure to publish large randomized trials presented at an oncology meeting.
Krzyzanowska MK; Pintilie M; Tannock IF
JAMA; 2003 Jul; 290(4):495-501. PubMed ID: 12876092
[TBL] [Abstract][Full Text] [Related]
10. Quality of abstracts describing randomized trials in the proceedings of American Society of Clinical Oncology meetings: guidelines for improved reporting.
Krzyzanowska MK; Pintilie M; Brezden-Masley C; Dent R; Tannock IF
J Clin Oncol; 2004 May; 22(10):1993-9. PubMed ID: 15143092
[TBL] [Abstract][Full Text] [Related]
11. Distribution and trends of hematology and oncology research in Latin America: A decade of uncertainty.
Acevedo AM; Gómez A; Becerra HA; Ríos AP; Zambrano PC; Obando EP; Martí-Carvajal AJ; Carranza H; Vargas CA; Otero JM; Reveiz L; Cardona AF
Cancer; 2014 Apr; 120(8):1237-45. PubMed ID: 24382827
[TBL] [Abstract][Full Text] [Related]
12. Publication outcomes of phase II oncology clinical trials.
Hoeg RT; Lee JA; Mathiason MA; Rokkones K; Serck SL; Crampton KL; Emmel AE; Severson EA; Go RS
Am J Clin Oncol; 2009 Jun; 32(3):253-7. PubMed ID: 19349853
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin use in oncology: a summary of the evidence and practice guidelines comparing efforts of the Cochrane Review group and Blue Cross/Blue Shield to set up the ASCO/ASH guidelines.
Djulbegovic B
Best Pract Res Clin Haematol; 2005; 18(3):455-66. PubMed ID: 15792920
[TBL] [Abstract][Full Text] [Related]
14. Improving the quality of abstract reporting for economic analyses in oncology.
Ho MY; Chan KK; Peacock S; Cheung WY
Curr Oncol; 2012 Dec; 19(6):e428-35. PubMed ID: 23300367
[TBL] [Abstract][Full Text] [Related]
15. An Analysis of Duplicate Presentations at the 2014 Through 2016 AOSSM and AANA Annual Meetings.
Kraeutler MJ; Carver TJ; McCarty EC
Orthop J Sports Med; 2017 Jul; 5(7):2325967117718531. PubMed ID: 28781977
[TBL] [Abstract][Full Text] [Related]
16. An observational study of duplicate presentation rates between two national orthopedic meetings.
Bhandari M; Patenall V; Devereaux PJ; Tornetta P; Dirschl D; Leece P; Ramanan T; Schemitsch EH
Can J Surg; 2005 Apr; 48(2):117-22. PubMed ID: 15887791
[TBL] [Abstract][Full Text] [Related]
17. The North American Menopause Society: from abstract to publication.
Schnatz PF; Romegialli A; Abrantes J; Marakovits K; Cunningham D; O'Sullivan DM;
Menopause; 2008; 15(5):996-1001. PubMed ID: 18446091
[TBL] [Abstract][Full Text] [Related]
18. The geography of clinical cancer research: analysis of abstracts presented at the American Society of Clinical Oncology Annual Meetings.
Saad ED; Mangabeira A; Masson AL; Prisco FE
Ann Oncol; 2010 Mar; 21(3):627-632. PubMed ID: 19717537
[TBL] [Abstract][Full Text] [Related]
19. Presentation and subsequent publication rates of phase I oncology clinical trials.
Camacho LH; Bacik J; Cheung A; Spriggs DR
Cancer; 2005 Oct; 104(7):1497-504. PubMed ID: 16116590
[TBL] [Abstract][Full Text] [Related]
20. Publication rate of abstracts from the annual ASTRO meeting: comparison with other organizations.
Papagikos MA; Rossi PJ; Lee WR
J Am Coll Radiol; 2005 Jan; 2(1):72-5. PubMed ID: 17411764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
